Tag: Isaac T. Kohlberg

  • Nation & World

    ‘Any patient with any disease’

    Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”

    4 minutes
    Chad Cowen
  • Nation & World

    Beam Therapeutics receives Harvard license

    Harvard University has granted a worldwide license to Beam Therapeutics Inc. to develop and commercialize a suite of revolutionary DNA base editing technologies for treating human disease.

    6 minutes
    David Liu
  • Nation & World

    Seeding startups

    For advanced technologies across the University, a new entrepreneur-in-residence program launched by Harvard Office of Technology Development might offer a crucial bridge to commercial development.

    10 minutes
  • Nation & World

    $50M gift from the Blavatnik Family Foundation

    The Blavatnik Family Foundation, headed by Len Blavatnik, M.B.A. ’89, has donated $50 million to Harvard University. The gift will launch a major initiative to expedite the development of basic science discoveries into new breakthrough therapies for patients and cures for disease. The gift underpins Harvard’s growing commitment to creating an entrepreneurial culture in the…

    3 minutes